Niacinamide ascorbate

Identification

Generic Name
Niacinamide ascorbate
DrugBank Accession Number
DB14486
Background

Not Available

Type
Small Molecule
Groups
Approved, Nutraceutical
Structure
Weight
Average: 298.251
Monoisotopic: 298.080100799
Chemical Formula
C12H14N2O7
Synonyms
  • Ascorbic acid nicotinamide complex
  • Niacinamide ascorbate
  • Nicotinamide-ascorbic acid complex

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AmphetamineThe serum concentration of Amphetamine can be decreased when it is combined with Niacinamide ascorbate.
BenzphetamineThe serum concentration of Benzphetamine can be decreased when it is combined with Niacinamide ascorbate.
BleomycinThe therapeutic efficacy of Bleomycin can be decreased when used in combination with Niacinamide ascorbate.
BortezomibThe therapeutic efficacy of Bortezomib can be decreased when used in combination with Niacinamide ascorbate.
ChlorpropamideNiacinamide ascorbate may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Active Moieties
NameKindUNIICASInChI Key
Ascorbic acidcomplexPQ6CK8PD0R50-81-7CIWBSHSKHKDKBQ-JLAZNSOCSA-N
Nicotinamidecomplex25X51I8RD498-92-0DFPAKSUCGFBDDF-UHFFFAOYSA-N
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Daily Balance TabNiacinamide ascorbate (60 mg / tab) + Niacinamide ascorbate (20 mg / tab) + Beta carotene (1000 unit / tab) + Cyanocobalamin (6 mcg / tab) + D-alpha-Tocopherol acetate (30 unit / tab) + Folic acid (.4 mg / tab) + Calcium pantothenate (10 mg / tab) + Pyridoxine hydrochloride (2 mg / tab) + Riboflavin (1.7 mg / tab) + Thiamine mononitrate (1.5 mg / tab) + Vitamin A acetate (4000 unit / tab) + Vitamin D (400 unit / tab)TabletOralPharmavite1995-12-311998-09-08Canada flag
Daily Balance TabNiacinamide ascorbate (60 mg / tab) + Niacinamide ascorbate (20 mg / tab) + Beta carotene (1000 unit / tab) + Cyanocobalamin (6 mcg / tab) + D-alpha-Tocopherol acetate (30 unit / tab) + Folic acid (.4 mg / tab) + Calcium pantothenate (10 mg / tab) + Pyridoxine hydrochloride (2 mg / tab) + Riboflavin (1.7 mg / tab) + Thiamine mononitrate (1.5 mg / tab) + Vitamin A acetate (4000 unit / tab) + Vitamin D (400 unit / tab)TabletOralPharmavite1995-12-311998-09-08Canada flag
Multiple Vitamins With Iron TabletsNiacinamide ascorbate (60 mg / tab) + Cyanocobalamin (6 mcg / tab) + DL-alpha tocopheryl acetate (30 unit / tab) + Ferrous fumarate (4 mg / tab) + Folic acid (.4 mg / tab) + Nicotinamide (20 mg / tab) + Calcium pantothenate (10 mg / tab) + Pyridoxine hydrochloride (2 mg / tab) + Riboflavin (1.7 mg / tab) + Thiamine mononitrate (1.5 mg / tab) + Vitamin A acetate (5000 unit / tab) + Vitamin D (400 unit / tab)TabletOralPharmavite1995-12-312000-08-24Canada flag
Nutrifer Plus TabletsNiacinamide ascorbate (25 mg) + Niacinamide ascorbate (150 mg) + Calcium (125 mg) + Cholecalciferol (400 unit) + Copper (1 mg) + Cyanocobalamin (5 mcg) + Ferrous fumarate (60 mg) + Folic acid (1 mg) + Riboflavin (2 mg) + Thiamine mononitrate (4.5 mg) + Vitamin A palmitate (5000 unit)TabletOralWyeth Ayerst Canada Inc.1994-12-311999-09-23Canada flag
Nutrifer Plus TabletsNiacinamide ascorbate (25 mg) + Niacinamide ascorbate (150 mg) + Calcium (125 mg) + Cholecalciferol (400 unit) + Copper (1 mg) + Cyanocobalamin (5 mcg) + Ferrous fumarate (60 mg) + Folic acid (1 mg) + Riboflavin (2 mg) + Thiamine mononitrate (4.5 mg) + Vitamin A palmitate (5000 unit)TabletOralWyeth Ayerst Canada Inc.1994-12-311999-09-23Canada flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Se-NatalNiacinamide ascorbate (120 mg/1) + Calcium carbonate (250 mg/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (12 ug/1) + DL-alpha tocopheryl acetate (30 [iU]/1) + Docusate sodium (50 mg/1) + Ergocalciferol (400 [iU]/1) + Ferrous fumarate (90 mg/1) + Folic acid (1 mg/1) + Niacin (20 mg/1) + Potassium Iodide (150 ug/1) + Pyridoxine hydrochloride (20 mg/1) + Riboflavin (3.4 mg/1) + Thiamine mononitrate (3 mg/1) + Vitamin A acetate (4000 [iU]/1) + Zinc oxide (25 ug/1)TabletOralSeton Pharmaceuticals2009-04-162011-07-31US flag
Se-Natal OneNiacinamide ascorbate (80 mg/1) + Biotin (30 ug/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (3 mg/1) + Cyanocobalamin (2.5 ug/1) + DL-alpha tocopheryl acetate (15 [iU]/1) + Ferrous fumarate (60 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (100 mg/1) + Nicotinamide (17 mg/1) + Pantothenic acid (7 mg/1) + Pyridoxine hydrochloride (4 mg/1) + Riboflavin (1.6 mg/1) + Thiamine hydrochloride (1.5 mg/1) + Vitamin A acetate (4000 [iU]/1) + Zinc oxide (25 mg/1)TabletOralSeton Pharmaceuticals2009-04-162011-12-21US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
JTL8B7TVW7
CAS number
1987-71-9
InChI Key
JMORAWFVNMGOKQ-MGMRMFRLSA-N
InChI
InChI=1S/C6H6N2O.C6H8O6/c7-6(9)5-2-1-3-8-4-5;7-1-2(8)5-3(9)4(10)6(11)12-5/h1-4H,(H2,7,9);2,5,7-10H,1H2/t;2-,5+/m.0/s1
IUPAC Name
(5R)-5-(1,2-dihydroxyethyl)-3,4-dihydroxy-2,5-dihydrofuran-2-one; pyridine-3-carboxamide
SMILES
NC(=O)C1=CN=CC=C1.[H]C(O)(CO)[C@@]1([H])OC(=O)C(O)=C1O

References

General References
Not Available
ChemSpider
18895044

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, film coatedOral
TabletOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility245.0 mg/mLALOGPS
logP-1.6ALOGPS
logP-1.9Chemaxon
logS0.14ALOGPS
pKa (Strongest Acidic)4.36Chemaxon
pKa (Strongest Basic)-3Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area107.22 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity37.03 m3·mol-1Chemaxon
Polarizability15.03 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-135.6934793
predicted
DarkChem Lite v0.1.0
[M-H]-159.36583
predicted
DeepCCS 1.0 (2019)
[M+H]+136.8643793
predicted
DarkChem Lite v0.1.0
[M+H]+161.7614
predicted
DeepCCS 1.0 (2019)
[M+Na]+135.3103793
predicted
DarkChem Lite v0.1.0
[M+Na]+168.46751
predicted
DeepCCS 1.0 (2019)

Drug created at July 06, 2018 22:30 / Updated at December 01, 2022 11:28